恒指升幅扩至逾500点突破二万七关 港交所涨近3%再破顶
台湾及南韩股市今天高收升1.5%-1.9%齐再创纪录高。港股今天发力追落後,恒指於期结日继续在科技股大幅回升推动,3时过後突破二万七关,报27,094,升幅扩至525点或2%,成交额1,308亿元。
腾讯(00700.HK)升幅扩至5.7%高见563元;阿里巴巴(09988.HK)升幅扩至逾6%高见236.4元;美团(03690.HK)涨近半成高见289.8元。此外,润地(01109.HK)、百威亚太(01876.HK)、舜宇(02382.HK)、蒙牛(02319.HK)及药明生物(02269.HK)升3.5%-4.6%,後两者分别高见46.9元及98.8元纪录高。此外,港交所(00388.HK)回升2.9%高见425元纪录高。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.